FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 40 filers reported holding FATE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $588,600 | -16.6% | 58,335 | +85.2% | 0.00% | -50.0% |
| Q3 2022 | $706,000 | +91.3% | 31,500 | +111.4% | 0.00% | +100.0% |
| Q2 2022 | $369,000 | -77.9% | 14,900 | -65.4% | 0.00% | -80.0% |
| Q1 2022 | $1,671,000 | +203.8% | 43,100 | +358.5% | 0.01% | +150.0% |
| Q4 2021 | $550,000 | +120.9% | 9,400 | +243.1% | 0.00% | +100.0% |
| Q4 2020 | $249,000 | +12350.0% | 2,740 | +149.1% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 1,100 | -15.4% | 0.00% | – |
| Q1 2016 | $2,000 | -94.3% | 1,300 | -87.4% | 0.00% | – |
| Q4 2015 | $35,000 | +25.0% | 10,300 | +94.3% | 0.00% | – |
| Q3 2015 | $28,000 | +460.0% | 5,300 | +657.1% | 0.00% | – |
| Q2 2015 | $5,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |